Embryos in a dish


Walter Isaacson on how gene editing will change lives

CRISPR has enabled us to manipulate the code of life. Where might it take us next?

Player utilities

Listen to the story.

Lab experiments aimed at fixing defective DNA in human embryos gave a new look at gene editing. Leading scientists say it’s too unsafe to try.


Mark Schiefelbein/AP Photo

Walter Isaacson has made a habit of profiling world-changers: innovators who, through their discoveries, upend the way we live. Recently, he’s been preoccupied with individuals who have unlocked what he calls “fundamental kernels of our existence” — first, Albert Einstein and the atom, then Steve Jobs and the bit, and now, in his latest work, Jennifer Doudna and the gene.

In "The Code Breaker," Isaacson dives into the CRISPR revolution and how the booming field of gene editing is altering how we treat disease and think about what it means to be human. Doudna, who shared the 2020 Nobel Prize in Chemistry for her role in developing CRISPR, is Isaacson’s centerpiece as he guides readers through this new frontier and the pressing moral questions that sophisticated, cutting-edge biological tools now pose. 

Three takeaways

  • The technology underpinning CRISPR-based gene editing is derived from the unique immune system of bacteria, which takes a genetic “mug shot” of invading viruses. This allows bacteria to recognize, target and demolish viruses that attack again. Humans have harnessed this natural phenomenon to create gene-editing tools that can target and alter human DNA.
  • Isaacson predicts we’re entering a biotech revolution that will be “20 times more important” than the dawning of the digital age. “Connecting our ability to code microchips with our ability to code molecules'' will, according to Isaacson, allow humans to understand and alter our biology in stunning ways. He thinks curing devastating diseases should be our first priority instead of trying to enhance our species.
  • Isaacson began to profile Doudna years before she was a Nobel Prize winner. He says he chose her over other CRISPR titans because of her engagement with CRISPR’s ethical issues and preoccupation with RNA over DNA, which Isaacson considers the “more interesting molecule.” RNA, the centerpiece of Doudna’s scientific studies, acts as a middleman between DNA and proteins and has been central to both CRISPR and the development of COVID vaccines. 

Related Stories


We use cookies to understand how you use our site and to improve your experience. To learn more, review our Cookie Policy. By continuing to use our site, you accept our use of cookies and Privacy Policy.

Ok, I understand. Close

The story you just read is freely available and accessible to everyone because readers like you support The World financially. 

Thank you all for helping us reach our goal of 1,000 donors. We couldn’t have done it without your support. Your donation directly supported the critical reporting you rely on, the consistent reporting you believe in, and the deep reporting you want to ensure survives. 

DONATE TODAY > No thanks